Pure Biologics

Pure Biologics Capital Intensity

The Capital Intensity Ratio of Pure Biologics (PUR.WA) as of Nov 12, 2026 is 23,934.74 %. In the previous year, Capital Intensity Ratio was 4,986.25 % — a change of 380.01% (higher).

Capital Intensity

23,934.74 %

YoY

380.01%

Last updated:

Capital Intensity Ratio of Pure Biologics is 2023 23,934.74 % . Capital Intensity Ratio of Pure Biologics was 2022 4,986.25 % . It decreases by 380.01% higher compared to the previous year.

The Pure Biologics Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2016
73.85 PLN
Jan 1, 2017
135.09 PLN
Jan 1, 2018
69.01 PLN
Jan 1, 2019
130.04 PLN
Jan 1, 2020
3,311.54 PLN
Jan 1, 2021
18,578.74 PLN
Jan 1, 2022
4,986.25 PLN
Jan 1, 2023
23,934.74 PLN
The Pure Biologics Capital Intensity history
YEARCapital IntensityYoY
23,934.74 %+380.01%
4,986.25 %-73.16%
18,578.74 %+461.03%
3,311.54 %+2,446.53%
130.04 %+88.43%
69.01 %-48.91%
135.09 %+82.93%
73.85 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics SA, headquartered in Wrocław, Poland, operates in the Health Care sector as a biotechnology company. It focuses on research and development of innovative biological medicines and medical devices for therapeutic and diagnostic applications. The company employs 53 full-time staff and was listed on the stock market on 11 December 2018. Founded in August 2010, it remains based in Wrocław, focusing on biopharmaceutical solutions. Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

Capital Intensity Ratio of Pure Biologics is 23,934.74 % in 2023.

Capital Intensity Ratio of Pure Biologics changed from 4,986.25 % to 23,934.74 %, representing a 380.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Pure Biologics with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Pure Biologics

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Pure Biologics